lumacaftor
SpainDrugs containing this active substance
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 6 years of age or older who have a specific mutation called F508del in the CFTR gene.
Form: tablets, film-coated
Active substance Dosage lumacaftor 100 mg ivacaftor 125 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 1 year of age or older who have a specific mutation called F508del in the CFTR gene.
Form: granules
Active substance Dosage lumacaftor 100 mg ivacaftor 125 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 1 year of age or older who have a specific mutation called F508del in the CFTR gene.
Form: granules
Active substance Dosage lumacaftor 150 mg ivacaftor 188 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 6 years of age and older who have a specific mutation called F508del in the CFTR gene.
Form: tablets, film-coated
Active substance Dosage ivacaftor 125 mg lumacaftor 200 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited
-
It is used for the long-term treatment of cystic fibrosis (CF) in patients 1 year of age or older who have a specific mutation called F508del in the CFTR gene.
Form: granules
Active substance Dosage lumacaftor 75 mg ivacaftor 94 mg Manufacturer: Vertex Pharmaceuticals (Ireland) Limited